Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | ELTX | Common Stock | Sale | -$3.22K | -373 | -1.03% | $8.62 | 35.9K | Oct 18, 2021 | Direct | F1 |
Id | Content |
---|---|
F1 | The shares reported in this Form 4 were sold pursuant to a 10b5-1 trading plan adopted by the reporting person solely to satisfy tax or other government withholding obligations in connection with the vesting of Restricted Stock Awards ("RSAs") granted by the Issuer. |
Senior Vice President and Chief Medical Officer